Amedisys Inc. (NASDAQ: AMED) and LHC Group Inc. (NASDAQ: LHCG) are Home Health Care agencies competing. We will evaluate their institutional possession, profitability, danger, dividends, analyst recommendations, income, and valuation.
Earnings and Valuation
Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Amedisys Inc. 1.66B 2. Forty-six 119.35M three.23 37.50
LHC Group Inc. 1.81B 1.92 sixty-three. 57M 1. Seventy-seven sixty one.54
Demonstrates Amedisys Inc. And LHC Group Inc. The income per share (EPS), gross revenue, and valuation. LHC Group Inc. Seems to have a lower income but better revenue than Amedisys Inc. When an enterprise has a decreased charge-to-income approach, it is more affordable than its counterpart. Amedisys Inc. It is currently lower priced than LHC Group Inc. because it buys and sells at a lower price-to-profit ratio.
Profitability
Table 2 demonstrates the return on belongings, return on fairness and internet margins of Amedisys Inc. And LHC Group Inc.
Net Margins Return on Equity Return on Assets
Amedisys Inc. 7.19% 14.Nine% nine.1%
LHC Group Inc. 3. Fifty-one% 5.9% three.Eight%
Volatility & Risk
Amedisys Inc.’s 1.35 beta shows that its volatility is 35.00% more unstable than that of Standard & Poor’s 500. LHC Group Inc.’s 11.00% volatility competitively makes it much less risky than Standard & Poor’s 500 due to the 0.89 beta.
Liquidity
Amedisys Inc. Has a Current Ratio of 1.1 and a Quick Ratio of 1.1. Competitively, LHC Group Inc.’s Current Ratio is 1.6 and has a 1.6 Quick Ratio. LHC Group Inc.’s higher potential to pay brief and lengthy-time period duties than Amedisys Inc.
Analyst Recommendations
Ratings and Recommendations for Amedisys Inc. And LHC Group Inc. Can discover it at the next desk.
Sell Ratings Hold Ratings Buy Rating Rating Score
Amedisys Inc. Zero 4 2 2.33
LHC Group Inc. Zero three 3 2.50
Amedisys Inc. Has a mean charge target of $130.83 and a 2.30% upside potential. Conversely, LHC Group Inc.’s ability upside is five.29%, and its average fee target is $116.29. The outcomes furnished in advance show that LHC Group Inc. Seems more significantly favorable than Amedisys Inc., primarily based on analyst perception.
Insider and Institutional Ownership
Amedisys Inc. And LHC Group Inc. have stocks held with institutional traders’ aid as follows: ninety-three % and 96%. 1.1% is Amedisys Inc.’s share held by using insiders. Insiders Competitively had 1.3% of LHC Group Inc. Stocks.
Performance
Here are the Weekly, Monthly, Quarterly, Half Yearly, Yearly, and YTD PerfoPerformanceoth pretenders.
Performance (W) Performance (M) Performance (Q) Performance (HY) Performance (Y) Performance (YTD)
Amedisys Inc. -four.Sixty-three% -7.Seventy four% -nine.Seventy one% -1.6% 111.Fifty nine% 3.33%
LHC Group Inc. 0.Eleven% three.26% 5.01% eleven.Four% 78.78% 16.3%
For the past year, Amedisys Inc. Has had a weaker performance than LHC Group Inc.
Amedisys, Inc. and its subsidiaries give healthcare offerings in the United States. It operates via three segments: Home Health, Hospice, and Personal Care. The Home Health section offers more than a few offerings in the homes of individuals for the restoration of sufferers from surgical treatment, chronic incapacity, or terminal illness, in addition to preventing avoidable sanatorium readmissions via its professional nurses, physical and speech therapists, occupational therapists, and aides for its sufferers to complete their critical private obligations. The Hospice phase gives care designed to offer consolation and help for folks dealing with a terminal illness, heart disorder, pulmonary disease, AlzheimerÂ’s, HIV/AIDS, and most cancers. The Personal Care phase offers help for sufferers with the activities of each day living. As of March 1, 2017, the corporation owned and operated 420 care facilities in 34 states. Amedisys, Inc. was Turned based in 1982 in Baton Rouge, Louisiana.
